Latham & Watkins represented Unlearn in the transaction.Unlearn®, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller,…
Unlearn’s $50 Million Series B Financing
Latham & Watkins represented Unlearn in the transaction.Unlearn®, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller,…